Knight Therapeutics (KHTRF) Short Interest Ratio & Short Volume $4.41 +0.19 (+4.50%) As of 07/3/2025 12:33 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Knight Therapeutics Short Interest DataKnight Therapeutics (KHTRF) has a short interest of 397,900 shares. This marks a -17.28% decrease in short interest from the previous month. The short interest ratio (days to cover) is 128.4, indicating that it would take 128.4 days of the average trading volume of 2,887 shares to cover all short positions.Current Short Interest397,900 sharesPrevious Short Interest481,000 sharesChange Vs. Previous Month-17.28%Dollar Volume Sold Short$1.77 millionShort Interest Ratio128.4 Days to CoverLast Record DateJune 15, 2025Today's Trading Volume6,000 sharesAverage Trading Volume2,887 sharesToday's Volume Vs. Average208% Short Selling Knight Therapeutics? Sign up to receive the latest short interest report for Knight Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKHTRF Short Interest Over TimeKHTRF Days to Cover Over TimeKHTRF Percentage of Float Shorted Over Time Knight Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025397,900 shares $1.77 million -17.3%N/A128.4 $4.45 5/31/2025481,000 shares $2.04 million -2.7%N/A171.8 $4.25 5/15/2025494,400 shares $2.21 million 0.0%N/A197.8 $4.46 4/30/2025494,600 shares $2.17 million +4.8%N/A97 $4.38 4/15/2025472,100 shares $1.86 million +4.1%N/A143.1 $3.95 3/31/2025453,700 shares $1.91 million +3.3%N/A156.4 $4.22 3/15/2025439,100 shares $1.83 million -11.0%N/A141.6 $4.17 2/28/2025493,500 shares $1.89 million -1.3%N/A329 $3.83 2/15/2025500,000 shares $1.99 million +5.8%N/A416.7 $3.98 1/31/2025472,500 shares $1.87 million +14.4%N/A337.5 $3.96 Get the Latest News and Ratings for KHTRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025413,200 shares $1.53 million +9.7%N/A129.1 $3.70 12/31/2024376,600 shares $1.36 million +7.2%N/A198.2 $3.61 12/15/2024351,200 shares $1.31 million +3.0%N/A125.4 $3.73 11/30/2024341,000 shares $1.28 million -39.1%N/A7.3 $3.75 11/15/2024560,000 shares $2.06 million +62.2%N/A37.6 $3.69 10/31/2024345,200 shares $1.39 million +34.8%N/A119 $4.04 10/15/2024256,100 shares $1.07 million +17.4%N/A128.1 $4.19 9/30/2024218,100 shares $950.92 thousand -0.2%N/A94.8 $4.36 9/15/2024218,600 shares $966.21 thousand +5.5%N/A128.6 $4.42 8/31/2024207,300 shares $852.00 thousand +1.3%N/A76.8 $4.11 8/15/2024204,600 shares $840.91 thousand -2.7%N/A55.3 $4.11 7/31/2024210,300 shares $868.54 thousand -0.8%N/A70.1 $4.13 7/15/2024211,900 shares $885.74 thousand -0.4%N/A40 $4.18 6/30/2024212,700 shares $882.71 thousand -2.0%N/A44.3 $4.15 6/15/2024217,000 shares $902.72 thousand -3.6%N/A433.9 $4.16 5/31/2024225,000 shares $983.48 thousand +4.8%N/A59.2 $4.37 5/15/2024214,700 shares $942.53 thousand -3.0%N/A55.1 $4.39 4/30/2024221,400 shares $927.67 thousand +2.0%N/A82 $4.19 4/15/2024217,000 shares $909.23 thousand +3.8%N/A47.2 $4.19 3/31/2024209,100 shares $819.67 thousand -0.1%N/A7.1 $3.92 3/15/2024209,300 shares $830.92 thousand -10.4%N/A33.8 $3.97 2/29/2024233,600 shares $955.42 thousand -8.1%N/A21 $4.09 2/15/2024254,300 shares $1.04 million -0.9%N/A68.7 $4.11 1/15/2024230,500 shares $965.56 thousand -2.9%N/A74.3 $4.19 12/31/2023237,300 shares $939.71 thousand -2.4%N/A92.4 $3.96 12/15/2023243,100 shares $940.55 thousand -45.2%N/A47.7 $3.87 11/30/2023443,500 shares $1.72 million -7.7%N/A119.9 $3.88 11/15/2023480,300 shares $1.81 million -19.4%N/A64.9 $3.76 10/31/2023596,000 shares $1.94 million +103.6%N/A220.7 $3.26 10/15/2023292,800 shares $983.81 thousand +11.2%N/A6.6 $3.36I was wrong about Trump (Ad)I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.Let me show you exactly what we’re doing to prepare. 9/30/2023263,400 shares $874.54 thousand -32.5%N/A39.3 $3.32 9/15/2023390,400 shares $1.28 million +6.7%N/A61 $3.29 8/31/2023366,000 shares $1.25 million +16.0%N/A8715.1 $3.41 8/15/2023315,600 shares $1.04 million -8.8%N/A3156 $3.31 7/31/2023345,900 shares $1.27 million +19.7%N/A150.4 $3.66 7/15/2023289,100 shares $1.09 million -3.2%N/A321.2 $3.78 6/30/2023298,600 shares $1.08 million +42.3%N/A64.9 $3.62 6/15/2023209,900 shares $761.94 thousand -51.7%N/A8.2 $3.63 5/31/2023434,300 shares $1.58 million -29.6%N/A24.3 $3.63 5/15/2023616,700 shares $2.22 million +31.1%N/A1541.8 $3.60 4/30/2023470,400 shares $1.63 million +93.2%N/A470.4 $3.46 4/15/2023243,500 shares $881.47 thousand +42.6%N/A19.5 $3.62 3/31/2023170,800 shares $561.08 thousand +77.4%N/A27.5 $3.29 3/15/202396,300 shares $351.50 thousand -22.0%N/A53.5 $3.65 2/28/2023123,500 shares $463.50 thousand -5.6%N/A19.6 $3.75 2/15/2023130,800 shares $510.46 thousand -65.2%N/A1308 $3.90 1/31/2023375,700 shares $1.47 million -16.8%N/A46.4 $3.90 1/15/2023451,300 shares $1.79 million -12.5%N/A161.2 $3.96 12/30/2022515,700 shares $1.96 million +26.0%N/A13.3 $3.80 12/15/2022409,400 shares $1.58 million +69.3%N/A4094 $3.86 11/30/2022241,800 shares $961.88 thousand +103.7%N/A2418 $3.98 11/15/2022118,700 shares $472.19 thousand -43.1%N/A1187 $3.98 10/31/2022208,500 shares $817.74 thousand +37.4%N/A2085 $3.92 10/15/2022151,700 shares $579.04 thousand +31.8%N/A758.5 $3.82 9/30/2022115,100 shares $452.69 thousand +142.3%N/A115.1 $3.93 9/15/202247,500 shares $220.88 thousand -4.6%N/A0 $4.65 8/31/202249,800 shares $231.57 thousand +20.3%N/A124.5 $4.65 8/15/202241,400 shares $194.10 thousand -42.4%N/A6.2 $4.69 7/31/202271,900 shares $319.96 thousand -6.5%N/A359.5 $4.45 7/15/202276,900 shares $332.21 thousand -23.8%N/A256.3 $4.32 6/30/2022100,900 shares $401.58 thousand -22.2%N/A1009 $3.98 6/15/2022129,600 shares $528.77 thousand -19.4%N/A117.8 $4.08 5/31/2022160,700 shares $691.01 thousand +10.5%N/A47.3 $4.30 5/15/2022145,400 shares $588.87 thousand -2.1%N/A80.8 $4.05 4/30/2022148,500 shares $622.66 thousand +2.1%N/A148.5 $4.19 4/15/2022145,500 shares $611.10 thousand -51.5%N/A363.8 $4.20 3/31/2022300,100 shares $1.23 million +59.6%N/A1500.5 $4.11 3/15/2022188,000 shares $802.76 thousand -8.5%N/A626.7 $4.27 2/28/2022205,500 shares $871.32 thousand -6.2%N/A40.3 $4.24 2/15/2022219,000 shares $941.70 thousand -33.0%N/A64.4 $4.30 1/31/2022326,900 shares $1.43 million +41.8%N/A155.7 $4.36 1/15/2022230,600 shares $968.52 thousand -15.1%N/A2306 $4.20 12/31/2021271,600 shares $1.13 million -5.9%N/A39.9 $4.16 12/15/2021288,500 shares $1.15 million +5.1%N/A72.1 $4.00 11/30/2021274,400 shares $1.12 million -24.0%N/A40.4 $4.10 11/15/2021360,900 shares $1.53 million -14.1%N/A11.2 $4.23 10/29/2021420,100 shares $1.75 million +53.3%N/A131.3 $4.15 10/15/2021274,000 shares $1.18 million -38.8%N/A47.2 $4.32 9/30/2021447,700 shares $1.93 million -7.1%N/A81.4 $4.31 9/15/2021482,000 shares $2.01 million -3.2%N/A150.6 $4.16I was wrong about Trump (Ad)I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.Let me show you exactly what we’re doing to prepare. 8/31/2021497,800 shares $2.11 million -17.6%N/A54.1 $4.25 8/13/2021604,400 shares $2.73 million -6.5%N/A167.9 $4.51 7/30/2021646,700 shares $2.65 million +39.1%N/A6.4 $4.09 7/15/2021464,900 shares $1.94 million +21.9%N/A101.1 $4.18 6/30/2021381,500 shares $1.64 million -34.2%N/A5.5 $4.30 6/15/2021580,000 shares $2.52 million -16.3%N/A1933.3 $4.34 5/28/2021726,100 shares $3.15 million -11.1%N/A907.6 $4.33 5/14/2021817,000 shares $3.52 million +4.4%N/A907.8 $4.31 4/30/2021782,400 shares $3.45 million -25.9%N/A23.9 $4.40 4/15/20211,056,300 shares $4.45 million -7.3%N/A8.1 $4.21 3/31/20211,139,900 shares $4.92 million -19.0%N/A11.5 $4.31 3/15/20211,408,000 shares $5.95 million -26.0%N/A327.4 $4.23 2/26/20211,902,200 shares $8.07 million -5.1%N/A3804.4 $4.24 2/12/20212,004,500 shares $8.90 million -29.7%N/A208.8 $4.44 1/29/20212,852,200 shares $12.06 million -37.9%N/A316.9 $4.23 1/15/20213,093,500 shares $12.86 million +6.6%N/A499 $4.16 12/31/20204,594,900 shares $19.30 million +48.5%N/A216.7 $4.20 12/15/20203,093,500 shares $12.69 million +6.6%N/A499 $4.10 11/30/20202,903,000 shares $11.84 million +5.1%N/A205.9 $4.08 11/15/20202,763,400 shares $11.41 million +0.1%N/A307 $4.13 10/30/20202,761,100 shares $11.84 million +11.1%N/A13805.5 $4.29 10/15/20202,485,600 shares $10.76 million -6.1%N/A994.2 $4.33 9/30/20202,647,100 shares $11.54 million +0.6%N/A472.7 $4.36 9/15/20202,630,300 shares $12.27 million +1.6%N/A417.5 $4.67 8/31/20202,590,200 shares $12.32 million -1.3%N/A221.4 $4.76 8/14/20202,625,200 shares $13.43 million +0.7%N/A276.3 $5.12 7/31/20202,606,000 shares $13.59 million -3.9%N/A2004.6 $5.22 7/15/20202,712,700 shares $13.92 million +3.3%N/A1043.3 $5.13 KHTRF Short Interest - Frequently Asked Questions What is Knight Therapeutics' current short interest? Short interest is the volume of Knight Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 397,900 shares of KHTRF short. Learn More on Knight Therapeutics' current short interest. What is a good short interest ratio for Knight Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KHTRF shares currently have a short interest ratio of 128.0. Learn More on Knight Therapeutics's short interest ratio. Is Knight Therapeutics' short interest increasing or decreasing? Knight Therapeutics saw a decrease in short interest during the month of June. As of June 15th, there was short interest totaling 397,900 shares, a decrease of 17.3% from the previous total of 481,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Knight Therapeutics stock? Short selling KHTRF is an investing strategy that aims to generate trading profit from Knight Therapeutics as its price is falling. KHTRF shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Knight Therapeutics? A short squeeze for Knight Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KHTRF, which in turn drives the price of the stock up even further. How often is Knight Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KHTRF, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies 1933 Industries Short Interest 4Cable TV International Short Interest 4Front Ventures Short Interest AB Science Short Interest Aleafia Health Short Interest Almirall Short Interest Alvotech Short Interest American Green Short Interest Avant Brands Short Interest Avicanna Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:KHTRF) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KHTRF Stock Alerts